Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men

Julia L. Marcus,David V. Glidden,Vanessa McMahan,Javier R. Lama,Kenneth H. Mayer,Albert Y. Liu,Orlando Montoya-Herrera,Martin Casapia,Brenda Hoagland,Robert M. Grant

Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men

2014

Julia L. Marcus
David V. Glidden
Vanessa McMahan
Javier R. Lama
Kenneth H. Mayer
Albert Y. Liu
Orlando Montoya-Herrera
Martin Casapia
Brenda Hoagland
Robert M. Grant

Background: In addition to protecting against HIV acquisition, antiretroviral preexposure prophylaxis (PrEP) using topical 1% tenofovir gel reduced Herpes simplex virus type 2 (HSV-2) acquisition by 51% among women in the CAPRISA 004 study. We examined the

Keywords:

Tenofovir
Homosexuality Male
Young adult
Virology
Men who have sex with men
Emtricitabine/Tenofovir
Deoxycytidine
CAPRISA 004
Herpes simplex virus
Medicine
hiv acquisition

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations